NASDAQ
MLAB

Mesa Laboratories Inc

Scientific & Technical Instruments
Technology

Prices are adjusted according to historical splits.

Mesa Laboratories Inc Stock Price

Vitals

Today's Low:
$122.61
Today's High:
$127.68
Open Price:
$126.6813
52W Low:
$113.7227
52W High:
$205.6825
Prev. Close:
$127.36
Volume:
25407

Company Statistics

Market Cap.:
$685.74 million
Book Value:
72.009
Revenue TTM:
$219.27 million
Operating Margin TTM:
3.31%
Gross Profit TTM:
$116.55 million
Profit Margin:
0.83%
Return on Assets TTM:
0.68%
Return on Equity TTM:
0.47%

Company Profile

Mesa Laboratories Inc had its IPO on 1995-01-25 under the ticker symbol MLAB.

The company operates in the Technology sector and Scientific & Technical Instruments industry. Mesa Laboratories Inc has a staff strength of 698 employees.

Stock update

Shares of Mesa Laboratories Inc opened at $126.68 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $122.61 - $127.68, and closed at $122.87.

This is a -3.53% slip from the previous day's closing price.

A total volume of 25,407 shares were traded at the close of the day’s session.

In the last one week, shares of Mesa Laboratories Inc have slipped by -12.5%.

Mesa Laboratories Inc's Key Ratios

Mesa Laboratories Inc has a market cap of $685.74 million, indicating a price to book ratio of 2.4872 and a price to sales ratio of 3.9884.

In the last 12-months Mesa Laboratories Inc’s revenue was $219.27 million with a gross profit of $116.55 million and an EBITDA of $41.07 million. The EBITDA ratio measures Mesa Laboratories Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Mesa Laboratories Inc’s operating margin was 3.31% while its return on assets stood at 0.68% with a return of equity of 0.47%.

In Q2, Mesa Laboratories Inc’s quarterly earnings growth was a negative -65.7% while revenue growth was a positive 0.4%.

Mesa Laboratories Inc’s PE and PEG Ratio

Forward PE
35.2113
Trailing PE
374.5882
PEG
0

Its diluted EPS in the last 12-months stands at $0.34 per share while it has a forward price to earnings multiple of 35.2113 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Mesa Laboratories Inc’s profitability.

Mesa Laboratories Inc stock is trading at a EV to sales ratio of 4.9163 and a EV to EBITDA ratio of 33.7233. Its price to sales ratio in the trailing 12-months stood at 3.9884.

Mesa Laboratories Inc stock pays annual dividends of $0.64 per share, indicating a yield of 0.52% and a payout ratio of 1.94%.

Balance sheet and cash flow metrics

Total Assets
$642.61 million
Total Liabilities
$39.13 million
Operating Cash Flow
$-270000.00
Capital Expenditure
$270000
Dividend Payout Ratio
1.94%

Mesa Laboratories Inc ended 2024 with $642.61 million in total assets and $0 in total liabilities. Its intangible assets were valued at $642.61 million while shareholder equity stood at $387.72 million.

Mesa Laboratories Inc ended 2024 with $0 in deferred long-term liabilities, $39.13 million in other current liabilities, 334384000.00 in common stock, $72.79 million in retained earnings and $283.76 million in goodwill. Its cash balance stood at $32.38 million and cash and short-term investments were $32.38 million. The company’s total short-term debt was $2,806,000 while long-term debt stood at $175.50 million.

Mesa Laboratories Inc’s total current assets stands at $114.81 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $35.60 million compared to accounts payable of $5.59 million and inventory worth $35.56 million.

In 2024, Mesa Laboratories Inc's operating cash flow was $-270000.00 while its capital expenditure stood at $270000.

Comparatively, Mesa Laboratories Inc paid $0.02 in dividends in 2024.

Other key metrics

Current Trading Price
$122.87
52-Week High
$205.6825
52-Week Low
$113.7227
Analyst Target Price
$152.5

Mesa Laboratories Inc stock is currently trading at $122.87 per share. It touched a 52-week high of $205.6825 and a 52-week low of $205.6825. Analysts tracking the stock have a 12-month average target price of $152.5.

Its 50-day moving average was $131.42 and 200-day moving average was $157.36 The short ratio stood at 9.73 indicating a short percent outstanding of 0%.

Around 589.6% of the company’s stock are held by insiders while 9596.8% are held by institutions.

Frequently Asked Questions About Mesa Laboratories Inc

The stock symbol (also called stock or share ticker) of Mesa Laboratories Inc is MLAB

The IPO of Mesa Laboratories Inc took place on 1995-01-25

Similar Industry Stocks (Scientific & Technical Instruments)

Last Price
Chg
Chg%
ICDS LTD. (ICDSLTD)
$28.03
1.13
+4.2%
$104.43
-2.79
-2.6%
$23.18
-1.22
-5%
$455.05
-22.7
-4.75%
$1.04
0.15
+16.85%
$75.05
1.18
+1.6%
$2.1
-0.01
-0.47%
$3.75
0.03
+0.81%
$32.12
-0.11
-0.34%
$0.02
-0
-8.91%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment’s solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982

Address

12100 West Sixth Avenue, Lakewood, CO, United States, 80228